Physician profile
Jennifer E Bayer
NPI 1902804339
$1,046.26
in general payments reported to CMS, 2019-2025
10 companies · $261 in 2025
The $261 reported for 2025 was more than what a typical Adult Health (Nurse Practitioner) provider received nationally (typical 2025 total: $182).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $139 · 2023: $242 · 2024: $405 · 2025: $261.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $908.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $907.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $146.34 | 2023-2025 | Xarelto, Spravato |
| Abbott Laboratories | $129.02 | 2024 | Freestyle Libre 3 |
| Glaxosmithkline, LLC. | $124.09 | 2022 | |
| Novo Nordisk INC | $112.13 | 2025 | Wegovy |
| Kyowa Kirin, INC. | $111.94 | 2024 | Crysvita |
| Otsuka Pharmaceutical Development & Commercialization, INC. | $107.50 | 2023 | |
| Dexcom, INC. | $103.31 | 2025 | Dexcom G6 Transmitter, Dexcom Stelo Glucose Biosensor, Dexcom G7 Gss (161) |
| Alexion Pharmaceuticals, INC. | $92.06 | 2024 | |
| Boston Scientific Corporation | $72.45 | 2022-2024 | |
| Neurelis, INC. | $47.42 | 2024 | Valtoco |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jennifer Bayer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.